Sep 2026· Experimental Gerontology· pp.
113313
· 0 citations
Medicine
TL;DR
Among adults with CKM stages 0-3, cumNHHR exposure was associated with incident CVD, whereas NHHR change patterns did not show an independent association beyond baseline NHHR, highlighting the potential value of cumNHHR assessment for early CVD risk stratification.
Abstract
Background
Individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3 are free of clinical cardiovascular disease (CVD) but may already have metabolic and renal abnormalities that increase CVD susceptibility. This makes them a distinct target population for early risk stratification. Although non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) potentially reflects atherogenic lipid burden, its association with incident CVD in CKM stages 0-3 remains unclear.
Methods
Data were obtained from the China Health and Retirement Longitudinal Study. K-means clustering identified longitudinal NHHR patterns from 2012 to 2015, and cumulative NHHR (cumNHHR) was calculated as time-weighted exposure. Logistic regression was used to examine associations with incident CVD during 2015-2020 after adjustment for sociodemographic characteristics, lifestyle behaviors, BMI, and kidney function.
Results
Among 3996 participants, 764 (19.12%) developed CVD. Compared with the low-stable NHHR pattern, Clusters 2 and 3 had higher odds of incident CVD, with ORs of 1.28 (95% CI, 1.07-1.54) and 1.57 (95% CI, 1.27-1.95). However, these associations were no longer statistically significant after further adjustment for baseline NHHR. Each 1-unit increase in cumNHHR was associated with approximately 7% higher odds of CVD. Restricted cubic spline analyses showed a linear association between cumNHHR and CVD risk in CKM stages 0-3, with an inverted U-shaped association in CKM stages 0-2.
Conclusions
Among adults with CKM stages 0-3, cumNHHR exposure was associated with incident CVD, whereas NHHR change patterns did not show an independent association beyond baseline NHHR. These findings highlight the potential value of cumNHHR assessment for early CVD risk stratification.
Cardiovascular-kidney-metabolic (CKM) syndrome integrates metabolic abnormalities, chronic kidney disease, and cardiovascular disease (CVD), with stages 0–3 representing a critical window for primary prevention. Whether the Chinese visceral adiposity index (CVAI) adds predictive value for CVD in this population r...
Long Feng, Geng Yang, He-Song Zeng et al.· Cardiovascular Diabetology· 0 citations
Investigating the impact of cumulative CHG index on CVD development in individuals with CKM syndrome stages 0–3 and compared the predictive performances of triglyceride-glucose (TyG) index and CHG index for CVD suggests that longitudinal monitoring of CHG index and TyG index may provide additional information for CVD r...
Jiabaili Wang, Qian Liu, Meng-Hui Li et al.· Frontiers in Endocrinology· 0 citations
In T2DM, LDL-C burden and variability jointly identified patients at greater risk, especially for MI and cardiovascular mortality, especially in younger adults or longer-duration diabetes subgroups.
Dae-Jeong Koo, J. Park, Kyungdo Han et al.· Diabetes, obesity and metabo...· 0 citations
Advanced CKM syndrome is associated with long-term mortality outcomes including all-cause and cardiovascular death, underscoring the importance of early screening and staging of CKM syndrome to prevent disease progression and reduce mortality risk.
Lan-Lan Li, D. T. Lui, C. Fong et al.· Journal of the American Hear...· 0 citations
Early risk stratification may help prevent cardiometabolic multimorbidity (CMM) among adults at cardiovascular–kidney–metabolic (CKM) stages 0–3. We compared the estimated glucose disposal rate (eGDR), triglyceride–glucose (TyG) index, and atherogenic index of plasma (AIP) for incident CMM, disease transitions, and...
Zun-Wei Wang, Yan-Yan Liu, Yi-Tong Ling et al.· Frontiers in Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.